134 related articles for article (PubMed ID: 38846694)
1. The multi-factorial modes of action of urease in the pathogenesis of incontinence associated dermatitis.
Owen EJ; Heylen RA; Stewart K; Winyard PG; Jenkins ATA
Skin Health Dis; 2024 Jun; 4(3):e349. PubMed ID: 38846694
[TBL] [Abstract][Full Text] [Related]
2. Combination of urease inhibitor and antiseptic inhibits urea decomposition-induced ammonia production by Proteus mirabilis.
Mugita Y; Nakagami G; Minematsu T; Kitamura A; Sanada H
Int Wound J; 2020 Dec; 17(6):1558-1565. PubMed ID: 32851777
[TBL] [Abstract][Full Text] [Related]
3. Incontinence-associated dermatitis: reducing adverse events.
Rippon M; Colegrave M; Ousey K
Br J Nurs; 2016 Oct; 25(18):1016-1021. PubMed ID: 27734729
[TBL] [Abstract][Full Text] [Related]
4. Detecting and monitoring incontinence associated dermatitis: Does impedance spectroscopy have a part to play?
Owen EJ; Heylen RA; Stewart K; Winyard PG; Jenkins ATA
Proc Inst Mech Eng H; 2023 Mar; ():9544119231159178. PubMed ID: 36882988
[TBL] [Abstract][Full Text] [Related]
5. Selective detection of urease-producing bacteria on the genital skin surface in patients with incontinence-associated dermatitis.
Kohta M; Koyanagi H; Inagaki Y; Nishikawa K; Kobayashi N; Tamura S; Ishikawa M; Banno Y; Takekoshi K; Mano K; Sugama J
Int Wound J; 2023 Oct; 20(8):3289-3297. PubMed ID: 37095598
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of a hydrocolloid crusting method versus standard care in the treatment of incontinence-associated dermatitis among adult patients in an acute care setting: A randomised controlled trial.
Gunasegaran N; Ang SY; Ng YZ; Lee NES; Agus N; Lee CW; Ong CE; Mostafa SS; Aloweni F
J Tissue Viability; 2023 May; 32(2):171-178. PubMed ID: 36717288
[TBL] [Abstract][Full Text] [Related]
7. Bacterial invasion into the epidermis of rats with sodium lauryl sulphate-irritated skin increases damage and induces incontinence-associated dermatitis.
Koudounas S; Minematsu T; Mugita Y; Nakai A; Tobe H; Takizawa C; Kunimitsu M; Nakagami G; Sanada H
Int Wound J; 2023 Jan; 20(1):191-200. PubMed ID: 35916389
[TBL] [Abstract][Full Text] [Related]
8. An Exploratory Study of the Effects of the pH of Synthetic Urine on Skin Integrity in Healthy Participants.
Koudounas S; Bader DL; Voegeli D
Skin Pharmacol Physiol; 2022; 35(3):166-173. PubMed ID: 35093947
[TBL] [Abstract][Full Text] [Related]
9. Prevention and management of moisture-associated skin damage.
Voegeli D; Hillery S
Br J Nurs; 2021 Aug; 30(15):S40-S46. PubMed ID: 34379461
[TBL] [Abstract][Full Text] [Related]
10. A decade of research on Incontinence-Associated Dermatitis (IAD): Evidence, knowledge gaps and next steps.
Beeckman D
J Tissue Viability; 2017 Feb; 26(1):47-56. PubMed ID: 26949126
[TBL] [Abstract][Full Text] [Related]
11. A 3-in-1 perineal care washcloth impregnated with dimethicone 3% versus water and pH neutral soap to prevent and treat incontinence-associated dermatitis: a randomized, controlled clinical trial.
Beeckman D; Verhaeghe S; Defloor T; Schoonhoven L; Vanderwee K
J Wound Ostomy Continence Nurs; 2011; 38(6):627-34. PubMed ID: 21952346
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of topical skin products in the treatment and prevention of incontinence-associated dermatitis: a systematic review.
Pather P; Hines S; Kynoch K; Coyer F
JBI Database System Rev Implement Rep; 2017 May; 15(5):1473-1496. PubMed ID: 28498177
[TBL] [Abstract][Full Text] [Related]
13. Improving diaper design to address incontinence associated dermatitis.
Beguin AM; Malaquin-Pavan E; Guihaire C; Hallet-Lezy AM; Souchon S; Homann V; Zöllner P; Swerev M; Kesselmeier R; Hornung F; Smola H
BMC Geriatr; 2010 Nov; 10():86. PubMed ID: 21092161
[TBL] [Abstract][Full Text] [Related]
14. Time of Onset to Changes in Skin Condition During Exposure to Synthetic Urine: A Prospective Study.
Phipps L; Gray M; Call E
J Wound Ostomy Continence Nurs; 2019; 46(4):315-320. PubMed ID: 31274862
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of urease activity in the urinary tract pathogens Staphylococcus saprophyticus and Proteus mirabilis by dimethylsulfoxide (DMSO).
Deutch CE
J Appl Microbiol; 2020 May; 128(5):1514-1523. PubMed ID: 31860153
[TBL] [Abstract][Full Text] [Related]
16. Does the presence of bacterial urinary infection contribute to the development of incontinence-associated dermatitis? A scoping review.
Koudounas S; Mugita Y; Minematsu T; Nakagami G; Weller C; Sanada H
J Tissue Viability; 2021 May; 30(2):256-261. PubMed ID: 33579585
[TBL] [Abstract][Full Text] [Related]
17. Management of incontinence-associated dermatitis with a skin barrier protectant.
Southgate G; Bradbury S
Br J Nurs; 2016 May 12-25; 25(9):S20-9. PubMed ID: 27172503
[TBL] [Abstract][Full Text] [Related]
18. Incontinence-associated dermatitis: who is affected?
Pather P; Doubrovsky A; Jack L; Coyer F
J Wound Care; 2021 Apr; 30(4):261-267. PubMed ID: 33856906
[TBL] [Abstract][Full Text] [Related]
19. Synergistic inhibition of ureolytic activity and growth of
Svane S; Lyngsie MC; Klitgaard JK; Karring H
Heliyon; 2024 May; 10(10):e31209. PubMed ID: 38826744
[TBL] [Abstract][Full Text] [Related]
20. Whole-cell Proteus mirabilis urease inhibition by aminophosphinates for the control of struvite formation.
Grela E; Dziełak A; Szydłowska K; Mucha A; Kafarski P; Grabowiecka AM
J Med Microbiol; 2016 Oct; 65(10):1123-1129. PubMed ID: 27550502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
